董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Sarah B. Kavanagh | 女 | Independent Director | 68 | 34.08万美元 | 未持股 | 2025-08-14 |
| John A. Paulson | 男 | Chairman of the Board | 69 | 31.58万美元 | 未持股 | 2025-08-14 |
| Thomas J. Appio | 男 | Chief Executive Officer and Director | 63 | 382.84万美元 | 未持股 | 2025-08-14 |
| Amy B. Wechsler | 女 | Independent Director | 55 | 32.75万美元 | 0.30 | 2025-08-14 |
| Michael Goettler | 男 | Director | 58 | 未披露 | 未持股 | 2025-08-14 |
| Frank D. Lee | -- | Independent Director | -- | 未披露 | 未持股 | 2025-08-14 |
| Christian A. Garcia | -- | Independent Director | -- | 未披露 | 未持股 | 2025-08-14 |
| Richard C. Mulligan | -- | Independent Director | -- | 未披露 | 未持股 | 2025-08-14 |
| Sandra Leung | -- | Director | 64 | 未披露 | 未持股 | 2025-08-14 |
| Robert N. Power | 男 | Independent Director | 68 | 34.25万美元 | 1.61 | 2025-08-14 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Thomas J. Appio | 男 | Chief Executive Officer and Director | 63 | 382.84万美元 | 未持股 | 2025-08-14 |
| Steven Lee | 男 | Senior Vice President, Controller and Chief Accounting Officer | 55 | 未披露 | 未持股 | 2025-08-14 |
| Jean Jacques Charhon | -- | Executive Vice President and Chief Financial Officer and Chief Accounting Officer | -- | 未披露 | 未持股 | 2025-08-14 |
| Seana Carson | -- | Executive Vice President and General Counsel | -- | 未披露 | 未持股 | 2025-08-14 |
| Aimee J. Lenar | -- | Executive Vice President, US Pharma | -- | 未披露 | 未持股 | 2025-08-14 |
董事简历
中英对照 | 中文 | 英文- Sarah B. Kavanagh
-
Sarah B. Kavanagh是企业董事，自2011年起担任Ontario Securities Commission委员。Kavanagh从1999年到2010年在Scotia Capital Inc. 担任多个职位。她还曾在企业部门担任多个高级金融职位。Kavanagh毕业于Harvard Business School，持有工商管理硕士学位；马萨诸塞州威廉斯敦Williams College经济学文学学士学位。Kavanaghu2011年在Institute of Corporate Directors完成了董事教育项目。除了担任公共公司董事之外，Kavanagh也是American Stock Transfer and Canadian Stock Transfer董事和审计委员会主席；Sustainable Development Technology Corporation董事和审计委员会成员；Canadian Tie Bank董事。
Sarah B. Kavanagh serves as an independent director of the Company. She has also served on the board of BHC since July 2016. From 2011 through May 2016 Ms. Kavanagh served as a Commissioner of the Ontario Securities Commission, where she also served as Chairperson of the audit committee starting in 2014. Between 1999 and 2010 Ms. Kavanagh served in various senior investment banking roles at Scotia Capital Inc. including Vice-Chair and Co-Head of Diversified Industries Group, Head of Equity Capital Markets, and Head of Investment Banking. Prior to Scotia Capital, she held several senior financial positions with operating companies. She started her career as an investment banker with a bulge bracket firm in New York. Ms. Kavanagh graduated from Harvard Business School with an MBA and received a Bachelor of Arts degree in Economics from Williams College. Since 2013 Ms. Kavanagh has been a director of Hudbay Minerals Inc., a publicly traded Canadian mining corporation, and a member of the board of trustees of WPT Industrial REIT, formerly a publicly traded open-ended real estate investment trust. In addition to her public company directorships, she is a director of AST and Cymax Technologies Group and also serves as a director of Sustainable Development Technology Canada. She completed the Directors Education Program at the Institute of Corporate Directors in 2011. - Sarah B. Kavanagh是企业董事，自2011年起担任Ontario Securities Commission委员。Kavanagh从1999年到2010年在Scotia Capital Inc. 担任多个职位。她还曾在企业部门担任多个高级金融职位。Kavanagh毕业于Harvard Business School，持有工商管理硕士学位；马萨诸塞州威廉斯敦Williams College经济学文学学士学位。Kavanaghu2011年在Institute of Corporate Directors完成了董事教育项目。除了担任公共公司董事之外，Kavanagh也是American Stock Transfer and Canadian Stock Transfer董事和审计委员会主席；Sustainable Development Technology Corporation董事和审计委员会成员；Canadian Tie Bank董事。
- Sarah B. Kavanagh serves as an independent director of the Company. She has also served on the board of BHC since July 2016. From 2011 through May 2016 Ms. Kavanagh served as a Commissioner of the Ontario Securities Commission, where she also served as Chairperson of the audit committee starting in 2014. Between 1999 and 2010 Ms. Kavanagh served in various senior investment banking roles at Scotia Capital Inc. including Vice-Chair and Co-Head of Diversified Industries Group, Head of Equity Capital Markets, and Head of Investment Banking. Prior to Scotia Capital, she held several senior financial positions with operating companies. She started her career as an investment banker with a bulge bracket firm in New York. Ms. Kavanagh graduated from Harvard Business School with an MBA and received a Bachelor of Arts degree in Economics from Williams College. Since 2013 Ms. Kavanagh has been a director of Hudbay Minerals Inc., a publicly traded Canadian mining corporation, and a member of the board of trustees of WPT Industrial REIT, formerly a publicly traded open-ended real estate investment trust. In addition to her public company directorships, she is a director of AST and Cymax Technologies Group and also serves as a director of Sustainable Development Technology Canada. She completed the Directors Education Program at the Institute of Corporate Directors in 2011.
- John A. Paulson
-
John A. Paulson，他是Paulson & Co. Inc.的总裁兼投资组合经理。Paulson & Co. Inc.是美国证券交易委员会注册投资咨询公司，专门从事全球合并、事件套利和信贷策略。1994年创立Paulson & Co. Inc.之前，他曾担任Gruss Partners公司的普通合伙人，以及Bear Stearns公司的负责合并和收购的董事总经理。
John A. Paulson serves as an independent director of the Company. He has also served on the board of BHC since June 2017. Mr. Paulson is the President and Portfolio Manager of Paulson & Co. Inc., an SEC-registered investment management company specializing in global mergers, event arbitrage and credit strategies, which he founded in 1994. Prior to forming Paulson & Co. Inc., Mr. Paulson was a Partner of Gruss Partners and a Managing Director in mergers and acquisitions at Bear Stearns. Mr. Paulson graduated with a degree in finance from New York University in 1978 and his MBA from Harvard Business School in 1980. Mr. Paulson has been a director of BrightSphere Investment Group Inc., a publicly traded asset management holding company, since November 2018 and has served as Chairman since April 2020. He also currently serves as a member of the advisory board of Harvard Business School. Mr. Paulson previously served as a director of American International Group Inc., a multinational finance and insurance corporation, from May 2016 to June 2017. - John A. Paulson，他是Paulson & Co. Inc.的总裁兼投资组合经理。Paulson & Co. Inc.是美国证券交易委员会注册投资咨询公司，专门从事全球合并、事件套利和信贷策略。1994年创立Paulson & Co. Inc.之前，他曾担任Gruss Partners公司的普通合伙人，以及Bear Stearns公司的负责合并和收购的董事总经理。
- John A. Paulson serves as an independent director of the Company. He has also served on the board of BHC since June 2017. Mr. Paulson is the President and Portfolio Manager of Paulson & Co. Inc., an SEC-registered investment management company specializing in global mergers, event arbitrage and credit strategies, which he founded in 1994. Prior to forming Paulson & Co. Inc., Mr. Paulson was a Partner of Gruss Partners and a Managing Director in mergers and acquisitions at Bear Stearns. Mr. Paulson graduated with a degree in finance from New York University in 1978 and his MBA from Harvard Business School in 1980. Mr. Paulson has been a director of BrightSphere Investment Group Inc., a publicly traded asset management holding company, since November 2018 and has served as Chairman since April 2020. He also currently serves as a member of the advisory board of Harvard Business School. Mr. Paulson previously served as a director of American International Group Inc., a multinational finance and insurance corporation, from May 2016 to June 2017.
- Thomas J. Appio
-
ThomasJ.Appio自2018年8月以来一直担任Bausch+Lomb/International的总裁兼联席主管，此前曾于2016年8月至2018年7月担任该公司国际部执行Vice President兼公司集团主席。在2013年加入Bausch Health之前，Appio先生曾在Bausch+Lomb担任多个职位，包括北亚/日本Vice President以及大中华区和日本地区董事总经理。加入Bausch+Lomb之前，Appio在Schering-Plough任职23年，担任多个领导和运营职位。Appio先生拥有亚利桑那州立大学（Arizona State University，W.P.Carey School of Business）会计学理学学士学位。
Thomas J. Appio has been President & Co-Head Bausch + Lomb/International since August 2018 and was previously Executive Vice President, Company Group Chairman, International from August 2016 until July 2018. Prior to joining Bausch Health in 2013 Mr. Appio served in several positions with Bausch + Lomb, including as Vice President, North Asia/Japan and as Managing Director, Greater China and Japan. Prior to joining Bausch + Lomb, Mr. Appio served 23 years with Schering-Plough in a wide range of leadership and operations responsibilities. Mr. Appio holds a Bachelor of Science in Accounting from Arizona State University, W.P. Carey School of Business. - ThomasJ.Appio自2018年8月以来一直担任Bausch+Lomb/International的总裁兼联席主管，此前曾于2016年8月至2018年7月担任该公司国际部执行Vice President兼公司集团主席。在2013年加入Bausch Health之前，Appio先生曾在Bausch+Lomb担任多个职位，包括北亚/日本Vice President以及大中华区和日本地区董事总经理。加入Bausch+Lomb之前，Appio在Schering-Plough任职23年，担任多个领导和运营职位。Appio先生拥有亚利桑那州立大学（Arizona State University，W.P.Carey School of Business）会计学理学学士学位。
- Thomas J. Appio has been President & Co-Head Bausch + Lomb/International since August 2018 and was previously Executive Vice President, Company Group Chairman, International from August 2016 until July 2018. Prior to joining Bausch Health in 2013 Mr. Appio served in several positions with Bausch + Lomb, including as Vice President, North Asia/Japan and as Managing Director, Greater China and Japan. Prior to joining Bausch + Lomb, Mr. Appio served 23 years with Schering-Plough in a wide range of leadership and operations responsibilities. Mr. Appio holds a Bachelor of Science in Accounting from Arizona State University, W.P. Carey School of Business.
- Amy B. Wechsler
-
AmyB.Wechsler自2016年6月起担任董事会成员。她自2005年以来是纽约市的执业皮肤科医生。Wechsler博士是The Mind-Beauty Connection的作者，由Simon&Schuster于2008年出版。她获得皮肤病学和精神病学的董事会认证，也是the Weill Cornell Medical College的精神病学兼职临床教授。作为皮肤健康专家，Wechsler博士担任香奈儿皮肤护理公司（Chanel Skin Care）的顾问，也是认证培训师和知名KOL演讲者，有资格教授医生和其他医学专业人员使用各种皮肤病产品。Wechsler博士是几个医疗专业组织的活跃成员，包括美国皮肤病学会、美国精神病学协会、美国儿童和青少年精神病学学会、纽约独立医生协会、医师科学学会和皮肤癌基金会。Wechsler博士在纽约长老会医院佩恩·惠特尼诊所（New York Presbyterian Hospital’；s Payne Whitney Clinic）完成了精神病学住院医师资格和儿童与青少年精神病学研究员资格，并在纽约州立大学Downstate Medical Center完成了皮肤病学住院医师资格。
Amy B. Wechsler has served on the Board since June 2016. She has been a practicing dermatologist in New York City since 2005. Dr. Wechsler is the author of The Mind-Beauty Connection, published by Simon & Schuster in 2008. She is board certified in both dermatology and psychiatry and is also an Adjunct Clinical Professor in Psychiatry at the Weill Cornell Medical College. As an expert on skin health, Dr. Wechsler serves as an advisor for Chanel Skin Care and is also a certified trainer and well-known KOL Speaker, qualified to teach physicians and other medical professionals in the use of various dermatological products. Dr. Wechsler is an active member of several medical professional organizations, including the American Academy of Dermatology, the American Psychiatric Association, the American Academy of Child and Adolescent Psychiatry, the Independent Doctors of New York, The Physicians Scientific Society, and The Skin Cancer Foundation. Dr. Wechsler completed her residency in psychiatry and a fellowship in child and adolescent psychiatry at New York Presbyterian Hospital's Payne Whitney Clinic, and completed a residency in dermatology at SUNY Downstate Medical Center. - AmyB.Wechsler自2016年6月起担任董事会成员。她自2005年以来是纽约市的执业皮肤科医生。Wechsler博士是The Mind-Beauty Connection的作者，由Simon&Schuster于2008年出版。她获得皮肤病学和精神病学的董事会认证，也是the Weill Cornell Medical College的精神病学兼职临床教授。作为皮肤健康专家，Wechsler博士担任香奈儿皮肤护理公司（Chanel Skin Care）的顾问，也是认证培训师和知名KOL演讲者，有资格教授医生和其他医学专业人员使用各种皮肤病产品。Wechsler博士是几个医疗专业组织的活跃成员，包括美国皮肤病学会、美国精神病学协会、美国儿童和青少年精神病学学会、纽约独立医生协会、医师科学学会和皮肤癌基金会。Wechsler博士在纽约长老会医院佩恩·惠特尼诊所（New York Presbyterian Hospital’；s Payne Whitney Clinic）完成了精神病学住院医师资格和儿童与青少年精神病学研究员资格，并在纽约州立大学Downstate Medical Center完成了皮肤病学住院医师资格。
- Amy B. Wechsler has served on the Board since June 2016. She has been a practicing dermatologist in New York City since 2005. Dr. Wechsler is the author of The Mind-Beauty Connection, published by Simon & Schuster in 2008. She is board certified in both dermatology and psychiatry and is also an Adjunct Clinical Professor in Psychiatry at the Weill Cornell Medical College. As an expert on skin health, Dr. Wechsler serves as an advisor for Chanel Skin Care and is also a certified trainer and well-known KOL Speaker, qualified to teach physicians and other medical professionals in the use of various dermatological products. Dr. Wechsler is an active member of several medical professional organizations, including the American Academy of Dermatology, the American Psychiatric Association, the American Academy of Child and Adolescent Psychiatry, the Independent Doctors of New York, The Physicians Scientific Society, and The Skin Cancer Foundation. Dr. Wechsler completed her residency in psychiatry and a fellowship in child and adolescent psychiatry at New York Presbyterian Hospital's Payne Whitney Clinic, and completed a residency in dermatology at SUNY Downstate Medical Center.
- Michael Goettler
-
Michael Goettler自2020年11月16日合并结束以来，Michael Goettler一直担任Viatris的首席执行官和Viatris董事会成员。他的职责包括领导公司的整体业绩，执行与执行主席和董事会合作制定的战略，包括启动Viatris“Global Healthcare Gateway”的战略，以及其他职责。从2019年1月到合并结束，Goettler先生是辉瑞厄普约翰分部“厄普约翰”的集团总裁，他的职责包括领导该分部的绩效和战略，包括商业、研发、运营和授权职能。从2018年7月到2018年12月，Goettler先生担任执行副总裁，成立了产品部，后来成为Upjohn。Goettler先生还于2018年1月至2018年6月担任辉瑞炎症与免疫学全球总裁；2016年1月至2017年12月担任辉瑞罕见病业务全球总裁；2014年1月至2015年12月任辉瑞全球创新制药业务全球商务官、高级副总裁；2012年6月至2013年12月担任辉瑞专业护理欧洲区域总裁和欧洲管理团队主席。2015年至2020年，Goettler先生担任人口服务国际董事会成员，该组织是一家致力于改善发展中国家人民健康的全球组织。自2019年以来，Goettler先生一直是清华大学药学院咨询委员会的成员。
Michael Goettler has served as Viatris' CEO and on the Viatris Board since the closing of the Combination on November 16 2020. His responsibilities include leading the overall performance of the Company and executing on the strategies developed in collaboration with the Executive Chairman and the Board, among other responsibilities.From January 2019 until the closing of the Combination, Mr. Goettler was the Group President of Pfizer's Upjohn division, where his responsibilities included leading the division's performance and strategy, including commercial, R&D, operations and enabling functions. From July 2018 until December 2018 Mr. Goettler served as Executive Vice President, Established Products Division, which subsequently became Upjohn. Mr. Goettler also served as Global President of Pfizer Inflammation & Immunology from January 2018 until June 2018; Global President of Pfizer's Rare Disease Business from January 2016 until December 2017; Global Commercial Officer, Senior Vice President for Pfizer's Global Innovative Pharma Business from January 2014 until December 2015; and Regional President, Europe for Pfizer Specialty Care and Chair of the European Management Team from June 2012 until December 2013.From 2015 until 2020 Mr. Goettler served on the board of directors of Population Services International, a global organization dedicated to improving the health of people in the developing world. Since 2019 Mr. Goettler has been a member of the Tsinghua School of Pharmacy Advisory Board. - Michael Goettler自2020年11月16日合并结束以来，Michael Goettler一直担任Viatris的首席执行官和Viatris董事会成员。他的职责包括领导公司的整体业绩，执行与执行主席和董事会合作制定的战略，包括启动Viatris“Global Healthcare Gateway”的战略，以及其他职责。从2019年1月到合并结束，Goettler先生是辉瑞厄普约翰分部“厄普约翰”的集团总裁，他的职责包括领导该分部的绩效和战略，包括商业、研发、运营和授权职能。从2018年7月到2018年12月，Goettler先生担任执行副总裁，成立了产品部，后来成为Upjohn。Goettler先生还于2018年1月至2018年6月担任辉瑞炎症与免疫学全球总裁；2016年1月至2017年12月担任辉瑞罕见病业务全球总裁；2014年1月至2015年12月任辉瑞全球创新制药业务全球商务官、高级副总裁；2012年6月至2013年12月担任辉瑞专业护理欧洲区域总裁和欧洲管理团队主席。2015年至2020年，Goettler先生担任人口服务国际董事会成员，该组织是一家致力于改善发展中国家人民健康的全球组织。自2019年以来，Goettler先生一直是清华大学药学院咨询委员会的成员。
- Michael Goettler has served as Viatris' CEO and on the Viatris Board since the closing of the Combination on November 16 2020. His responsibilities include leading the overall performance of the Company and executing on the strategies developed in collaboration with the Executive Chairman and the Board, among other responsibilities.From January 2019 until the closing of the Combination, Mr. Goettler was the Group President of Pfizer's Upjohn division, where his responsibilities included leading the division's performance and strategy, including commercial, R&D, operations and enabling functions. From July 2018 until December 2018 Mr. Goettler served as Executive Vice President, Established Products Division, which subsequently became Upjohn. Mr. Goettler also served as Global President of Pfizer Inflammation & Immunology from January 2018 until June 2018; Global President of Pfizer's Rare Disease Business from January 2016 until December 2017; Global Commercial Officer, Senior Vice President for Pfizer's Global Innovative Pharma Business from January 2014 until December 2015; and Regional President, Europe for Pfizer Specialty Care and Chair of the European Management Team from June 2012 until December 2013.From 2015 until 2020 Mr. Goettler served on the board of directors of Population Services International, a global organization dedicated to improving the health of people in the developing world. Since 2019 Mr. Goettler has been a member of the Tsinghua School of Pharmacy Advisory Board.
- Frank D. Lee
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Christian A. Garcia
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Richard C. Mulligan
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Sandra Leung
-
Sandra Leung，最近担任Bristol Myers Squibb公司执行副总裁兼总法律顾问。Sandra曾在最高层提供战略法律顾问，帮助指导公司治理、合规和监管举措。
Sandra Leung,most recently as Executive Vice President and General Counsel of Bristol Myers Squibb Company. Sandra has provided strategic legal counsel at the highest levels, helping to guide corporate governance, compliance, and regulatory initiatives. - Sandra Leung，最近担任Bristol Myers Squibb公司执行副总裁兼总法律顾问。Sandra曾在最高层提供战略法律顾问，帮助指导公司治理、合规和监管举措。
- Sandra Leung,most recently as Executive Vice President and General Counsel of Bristol Myers Squibb Company. Sandra has provided strategic legal counsel at the highest levels, helping to guide corporate governance, compliance, and regulatory initiatives.
- Robert N. Power
-
Robert N. Power，他一直任职公司的董事会（2008年8月以来）。他曾担任宾夕法尼亚大学沃顿商学院（The Wharton School of Business, University of Pennsylvania）的教师，在那里他教授跨国营销（从2009年到2011年）。他拥有超过25年的制药和生物技术行业的工作经验，来自于担任Wyeth公司的多种领导职务（从1985年到2007年），包括新产品开发董事、英国爱尔兰董事总经理、全球营销副总裁、欧洲、中东、非洲的总裁、国际总裁、负责全球业务运营的执行副总裁。他已完成了美国企业董事联合会（ National Association of Corporate Directors）的董事专业课程。
Robert N. Power has served on the Board since August 2008. He is currently a corporate director. From 2009 to 2011 Mr. Power was a faculty member at The Wharton School of Business, University of Pennsylvania, where he taught multinational marketing. Mr. Power has over 25 years' experience working in the pharmaceutical and biotechnology industry, which he gained serving in a number of leadership positions with Wyeth from 1985 through 2007 including Director - New Product Development, Managing Director - U.K./Ireland, Vice President - Global Marketing, President - Europe, Middle East, Africa, President - International and Executive Vice President - Global Business Operations. Mr. Power also has completed the Director Professionalism course offered by the National Association of Corporate Directors. Mr. Power has a B.S. in statistics from the State University of New York and an M.S. in biostatistics from the Medical College of Virginia- Virginia Commonwealth University. - Robert N. Power，他一直任职公司的董事会（2008年8月以来）。他曾担任宾夕法尼亚大学沃顿商学院（The Wharton School of Business, University of Pennsylvania）的教师，在那里他教授跨国营销（从2009年到2011年）。他拥有超过25年的制药和生物技术行业的工作经验，来自于担任Wyeth公司的多种领导职务（从1985年到2007年），包括新产品开发董事、英国爱尔兰董事总经理、全球营销副总裁、欧洲、中东、非洲的总裁、国际总裁、负责全球业务运营的执行副总裁。他已完成了美国企业董事联合会（ National Association of Corporate Directors）的董事专业课程。
- Robert N. Power has served on the Board since August 2008. He is currently a corporate director. From 2009 to 2011 Mr. Power was a faculty member at The Wharton School of Business, University of Pennsylvania, where he taught multinational marketing. Mr. Power has over 25 years' experience working in the pharmaceutical and biotechnology industry, which he gained serving in a number of leadership positions with Wyeth from 1985 through 2007 including Director - New Product Development, Managing Director - U.K./Ireland, Vice President - Global Marketing, President - Europe, Middle East, Africa, President - International and Executive Vice President - Global Business Operations. Mr. Power also has completed the Director Professionalism course offered by the National Association of Corporate Directors. Mr. Power has a B.S. in statistics from the State University of New York and an M.S. in biostatistics from the Medical College of Virginia- Virginia Commonwealth University.
高管简历
中英对照 | 中文 | 英文- Thomas J. Appio
ThomasJ.Appio自2018年8月以来一直担任Bausch+Lomb/International的总裁兼联席主管，此前曾于2016年8月至2018年7月担任该公司国际部执行Vice President兼公司集团主席。在2013年加入Bausch Health之前，Appio先生曾在Bausch+Lomb担任多个职位，包括北亚/日本Vice President以及大中华区和日本地区董事总经理。加入Bausch+Lomb之前，Appio在Schering-Plough任职23年，担任多个领导和运营职位。Appio先生拥有亚利桑那州立大学（Arizona State University，W.P.Carey School of Business）会计学理学学士学位。
Thomas J. Appio has been President & Co-Head Bausch + Lomb/International since August 2018 and was previously Executive Vice President, Company Group Chairman, International from August 2016 until July 2018. Prior to joining Bausch Health in 2013 Mr. Appio served in several positions with Bausch + Lomb, including as Vice President, North Asia/Japan and as Managing Director, Greater China and Japan. Prior to joining Bausch + Lomb, Mr. Appio served 23 years with Schering-Plough in a wide range of leadership and operations responsibilities. Mr. Appio holds a Bachelor of Science in Accounting from Arizona State University, W.P. Carey School of Business.- ThomasJ.Appio自2018年8月以来一直担任Bausch+Lomb/International的总裁兼联席主管，此前曾于2016年8月至2018年7月担任该公司国际部执行Vice President兼公司集团主席。在2013年加入Bausch Health之前，Appio先生曾在Bausch+Lomb担任多个职位，包括北亚/日本Vice President以及大中华区和日本地区董事总经理。加入Bausch+Lomb之前，Appio在Schering-Plough任职23年，担任多个领导和运营职位。Appio先生拥有亚利桑那州立大学（Arizona State University，W.P.Carey School of Business）会计学理学学士学位。
- Thomas J. Appio has been President & Co-Head Bausch + Lomb/International since August 2018 and was previously Executive Vice President, Company Group Chairman, International from August 2016 until July 2018. Prior to joining Bausch Health in 2013 Mr. Appio served in several positions with Bausch + Lomb, including as Vice President, North Asia/Japan and as Managing Director, Greater China and Japan. Prior to joining Bausch + Lomb, Mr. Appio served 23 years with Schering-Plough in a wide range of leadership and operations responsibilities. Mr. Appio holds a Bachelor of Science in Accounting from Arizona State University, W.P. Carey School of Business.
- Steven Lee
Steven Lee，于2024年6月至2025年4月期间，在BrandSafway（Clayton，Dubilier & Rice和Brookfield Business Partners（“BrandSafway”）的投资组合公司）担任工业和能源部门以及北美部门的副总裁兼首席财务官。2022年4月-2023年11月，任BrandSafway副总裁兼首席会计官。在加入BrandSafway之前，Lee先生曾在Mohwak Industries担任过多个领导职务，包括2021年4月至2022年4月的副总裁、公司财务总监兼首席会计官,2018年至2021年3月的副总裁兼公司助理财务总监，以及2015年至2018年的Ceramic Europe副总裁兼首席财务官。
Steven Lee,served as Vice President and Chief Financial Officer of the Industrial and Energy Division, and the North America Division, from June 2024 to April 2025, for BrandSafway, a portfolio company of Clayton, Dubilier & Rice and Brookfield Business Partners ("BrandSafway"). From April 2022 through November 2023, he served as Vice President and Chief Accounting Officer of BrandSafway. Prior to joining BrandSafway, Mr. Lee served in various leadership roles at Mohwak Industries, including Vice President, Corporate Controller and Chief Accounting Officer from April 2021 through April 2022, Vice President and Assistant Corporate Controller from 2018 through March 2021 and Vice President, Chief Financial Officer, Ceramic Europe from 2015 through 2018.- Steven Lee，于2024年6月至2025年4月期间，在BrandSafway（Clayton，Dubilier & Rice和Brookfield Business Partners（“BrandSafway”）的投资组合公司）担任工业和能源部门以及北美部门的副总裁兼首席财务官。2022年4月-2023年11月，任BrandSafway副总裁兼首席会计官。在加入BrandSafway之前，Lee先生曾在Mohwak Industries担任过多个领导职务，包括2021年4月至2022年4月的副总裁、公司财务总监兼首席会计官,2018年至2021年3月的副总裁兼公司助理财务总监，以及2015年至2018年的Ceramic Europe副总裁兼首席财务官。
- Steven Lee,served as Vice President and Chief Financial Officer of the Industrial and Energy Division, and the North America Division, from June 2024 to April 2025, for BrandSafway, a portfolio company of Clayton, Dubilier & Rice and Brookfield Business Partners ("BrandSafway"). From April 2022 through November 2023, he served as Vice President and Chief Accounting Officer of BrandSafway. Prior to joining BrandSafway, Mr. Lee served in various leadership roles at Mohwak Industries, including Vice President, Corporate Controller and Chief Accounting Officer from April 2021 through April 2022, Vice President and Assistant Corporate Controller from 2018 through March 2021 and Vice President, Chief Financial Officer, Ceramic Europe from 2015 through 2018.
- Jean Jacques Charhon
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Seana Carson
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Aimee J. Lenar
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介